SCHEMBL23748725

SCHEMBL23748725

CCCCCOc1cccc(OC)c1C(=O)OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.52
SMPD1 P17405 4/20 0.49
HDAC6 Q9UBN7 2/20 0.49
LMNA P02545 2/20 0.49
MEN1 O00255 1/20 0.49
NR1I2 O75469 1/20 0.49
CHRM2 P08172 1/20 0.49
CYP3A4 P08684 1/20 0.49
ADRA2A P08913 1/20 0.49
MAPT P10636 1/20 0.49
OPRK1 P41145 1/20 0.49
HTR2B P41595 1/20 0.49
SLC6A3 Q01959 1/20 0.49
KMT2A Q03164 1/20 0.49
PTPN1 P18031 1/20 0.48
HDAC1 Q13547 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8085961 0.87 LMNA (0.55) HDAC6LMNAMEN1NR1I2CHRM2
SCHEMBL23748636 0.86 CA12 (0.66) PPARAHDAC6LMNAMEN1NR1I2
SCHEMBL9713311 0.85 CA9 (0.50) LMNAMEN1MAPTKMT2APTPN1
SCHEMBL20934599 0.85 LMNA (0.57) HDAC6LMNAMEN1NR1I2CHRM2
SCHEMBL9698411 0.85 PTPN1 (0.59) SMPD1HDAC6LMNAMEN1NR1I2
SCHEMBL8956310 0.85 PTPN1 (0.59) SMPD1HDAC6LMNAMEN1NR1I2
SCHEMBL17502688 0.84 TSHR (0.58) PPARALMNAMEN1CYP3A4MAPT
SCHEMBL11075449 0.83 TSHR (0.59) PPARALMNACYP3A4MAPTTP53
SCHEMBL17502731 0.83 TSHR (0.59) PPARALMNACYP3A4MAPTTP53
SCHEMBL17502748 0.83 TSHR (0.59) PPARALMNACYP3A4MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof BASF AS (NO) 2025-11-18 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
EP-3864001-A1 ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-08-18 EP disclosed
CN-113166024-A Aromatic compounds and their medical use 巴斯夫股份公司 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473249-B2 Aromatic compounds and pharmaceutical uses thereof GLS2, FFAR3, SLC10A1 PPARA 81/4885SMPD1 12/4885HDAC6 1494/4885
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF GLS2, FFAR3, SLC10A1 PPARA 81/4885SMPD1 12/4885HDAC6 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.